The average number of newly reported Covid-19 cases has remained high in the US over the past week, even though the Easter holiday led to a decrease in daily recorded infections and deaths.
While new business is lower than the highest in January, they have been rising higher over the past few days. The seven-day average, which eliminates irregularities in data reporting, was 64,628 on Saturday, while the 14-day average was 63,222, according to a Wall Street Journal analysis of data compiled by the Johns Hopkins university has been set up. If the seven-day average is higher than the 14-day average, as it has been since March 24, this indicates that the cases are rising. Half of the states report higher averages of seven days.
According to the latest data compiled by Johns Hopkins University, the US reported more than 34,000 new infections on Sunday. Newly reported cases tend to be lower at the beginning of the week as fewer people are tested during the weekend and some countries do not report data on Sundays and rise during the week.
The figure for Sunday, which was likely to be affected by the Easter holiday, is compared to more than 62,000 cases reported on Saturday and more than 43,000 a week earlier.
Hospitalizations have also leveled off, with states reporting between 50,000 and about 40,000 Covid-19 patients in hospitals over the past month, according to the latest data posted by the Department of Health and Human Services.
The number of U.S. deaths due to Covid-19 dropped to 222 on Sunday from 676 a day earlier. The seven-day average stood at 838 on Saturday, compared to an average of 14 days of 900. The U.S. has now reported more than 555,000 deaths from Covid-19 and more than 30.7 million infections.
The distribution of vaccines has increased, and the country has administered an average of 3.1 million vaccine doses in the past week, according to a journal analysis of data from the Centers for Disease Control and Prevention. More than 18% of the U.S. population is now fully vaccinated against Covid-19 and 32% have received at least one dose, according to CDC data.
Johnson & Johnson takes over the production of its Covid-19 vaccine at the factory from a contract manufacturer that manufactures the main ingredient, after a manufacturing problem ruined a lot. To give J&J full control, production of AstraZeneca’s vaccine at the Emergent BioSolutions Inc. plant in Baltimore will move elsewhere.
Despite the case of Covid-19 cases in most states from January highs and more people being vaccinated, life in most of the US is not back to normal, an analysis of the foot traffic data shows. Americans went out less in January, February and early March compared to the same period in 2020, before the pandemic forced state restrictions.